Special Issue "Involvement of Body Fluids in SARS-CoV-2 Infection"

A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "SARS-CoV-2 and COVID-19".

Deadline for manuscript submissions: closed (30 September 2021).

Special Issue Editor

Dr. Janis Müller
E-Mail Website
Guest Editor
Institute of Molecular Virology, Ulm University Medical Center, 89081 Ulm, Germany
Interests: emerging viruses; virus transmission; virus inhibition; extracellular vesicles

Special Issue Information

Dear colleagues,

SARS-CoV-2 RNA, or infectious virions, have been detected in various body fluids and secretions such as respiratory aerosols, saliva, bronchoalveolar lavage, plasma, breast milk or feces. Whether or not virus transmissions via all of these body fluids can occur is not entirely understood, but might be dependent on the virus origin and titers in the respective fluid. Furthermore, components in the body fluid might directly impact virus infectivity and prevent or foster transmission.

In this Special Issue of Viruses, we want to explore how SARS-CoV-2 enters and behaves in different body fluids or how the different body fluids impact SARS-CoV-2 infectivity. Biological fluids might contain antiviral activities that are based on peptides, proteins, lipids, or extracellular vesicles. Such entities might directly influence virus stability and infectivity and thus transmissibility. The understanding of what environment virus transmissions are likely, or why some transmission routes can be excluded, might reveal points of vulnerability of SARS-CoV-2 and lead to the development of new antiviral strategies. Thus, we here want to accumulate data on virus-interfering or -promoting substances in body fluids and drive the development of antiviral strategies crucially required to fight this and future pandemics.

Dr. Janis Müller
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • emerging viruses
  • virus transmission
  • virus inhibition
  • virucidal

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop